EUVIMEDEUVIMED entdecken
Crossref

Stratified modestly weighted log‐rank tests in settings with an anticipated delayed separation of survival curves

Dominic Magirr iD, José L Jiménez iD

Biometrical Journal · 2023

DOI: 10.1002/bimj.202200126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biometrical Journal, 2023. Verfasst von Dominic Magirr und 1 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Methodology and Data Science, Novartis Pharma AG, Basel, Switzerland. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Delayed separation of survival curves is a common occurrence in confirmatory studies in immuno‐oncology. Many novel statistical methods that aim to efficiently capture potential long‐term survival improvements have been proposed in recent years. However, the vast majority do not consider stratification, which is a major limitation considering that most large confirmatory studies currently employ a stratified primary analysis. In this article, we combine recently proposed weighted log‐rank tests that have been designed to work well under a delayed separation of survival curves, with stratification by a baseline variable. The aim is to increase the efficiency of the test when the stratifying variable is highly prognostic for survival. As there are many potential ways to combine the two techniques, we compare several possibilities in an extensive simulation study. We also apply the techniques retrospectively to two recent randomized clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansRetrospective StudiesComputer SimulationMedical OncologySurvival AnalysisProportional Hazards Models

Stichwörter der Autor:innen

delayed curve separationimmunotherapymodestly weighted log-rank teststratified analysis

Autor:innen und Institutionen

  • Advanced Methodology and Data Science, Novartis Pharma AG, Basel, Switzerland.
  • Global Drug Development, Novartis Pharma AG, Basel, Switzerland.

ORCID-Profile: Dominic Magirr, José L Jiménez

Zitieren

APA

Magirr, D., & Jiménez, J. L. (2023). Stratified modestly weighted log‐rank tests in settings with an anticipated delayed separation of survival curves. Biometrical Journal. https://doi.org/10.1002/bimj.202200126

Vancouver

Magirr D, Jiménez JL. Stratified modestly weighted log‐rank tests in settings with an anticipated delayed separation of survival curves. Biometrical Journal. 2023. doi:10.1002/bimj.202200126

BibTeX
@article{Magirr2023,
  author = {Magirr, Dominic and Jiménez, José L},
  title = {Stratified modestly weighted log‐rank tests in settings with an anticipated delayed separation of survival curves},
  journal = {Biometrical Journal},
  year = {2023},
  doi = {10.1002/bimj.202200126}
}
Kostenlos starten →